3D Printing for Healthcare Applications

Technology that could revolutionize pharmaceutical and biotechnology manufacturing

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

3D printing (3DP) will have a strong commercial impact across major consumer segments of the global healthcare sectors, an industry that necessitates efficient production of primarily complex or personalized products. The opportunity to customize drugs, active pharmaceutical ingredients (APIs) and medical devices drives an era of personalized medicine. 3D printing has garnered a place on the finisher’s podium as one of the highly investigated technologies for potential adoption by a plethora of key participants in the healthcare industry.

Table of Contents

1.0 Executive Summary1.1 Research Methodology 1.2 Key Findings 2.0 Overview and Definition2.1 Aspects of 3D Printing versus Traditional Manufacturing2.2 Crowdsourcing and 3D Printing2.3 Crowdsourcers Leading the Change2.4 Mass Customization and 3D Printing3.0 3D Printing Technology Landscape3.1 Major 3D Printing Technologies3.2 Comparative Analysis of 3D Printing Technologies4.0 Assessment of 3D Printing across Healthcare4.1 3D Printing has a Dynamic Impact across Multiple Verticals, which Largely Include the Healthcare and Industrial Sectors4.2 3D Printing Is a Platform for Innovation across Healthcare4.3 Recent Events across the Healthcare Industry Due to 3D Printing 4.4 Prosthetics, Bone Grafts, and Dental Prosthetics have the Highest Innovation and Adoption rates for 3D Printing Applications4.5 Prosthetics, Bone Grafts, and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications4.6 Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications 4.7 Prosthetics, Bone Grafts, Ears and Vascular Tissues and Dental Prosthetics with the Highest Innovation and Adoption Rates for 3D Printing Applications 5.0 Competency of 3D Printing across Healthcare 5.1 Business Model of Additive Manufacturing 3D Printer Manufacturers 5.2 Business Model of Additive Manufacturing Material Providers 5.3 Business Model of Additive Manufacturing Service Providers 5.4 Comparative Assessment of 3D Printing Technologies 5.4 Comparative Assessment of 3D Printing Technologies (continued)5.5 Company Profile – Stratasys5.6 Stratasys Activities in the Dental Industry – These dental 3D Printers are having a Huge Impact on the Dental Industry5.7 The Use of Stratasys Printers in the Dental Industry – Case Studies Being used for Various Application in the Dental Industry5.8 Stratasys Activities in the Healthcare Industry5.9 The Use of Stratasys Printers in the Healthcare Industry5.10 Company Profile – 3D Systems5.11 3D Systems’ Activities in the Healthcare Industry5.12 3D Systems’ Printers Used in the Healthcare Industry6.0 Assessment of Potential Applications – Pharmaceutical 6.1 3D Printing – Key Areas of Impact across the Pharmaceutical Sector 6.2.1 Disease Treatment and Drug Discovery Process: Pharmaceutical Requirement from 3DP 6.2.2 Disease Treatment and Drug Discovery Process: 3DP Impact on Drug Discovery Value Chain 6.2.3 Disease Treatment and Drug Discovery Process: Innovations across Manufacturing Techniques 6.2.4 Disease Treatment and Drug Discovery Process: Impact of Printers across Pharma Innovations 6.2.5 Disease Treatment and Drug Discovery Process: 3D Printing Impact across Pharma Innovations 6.2.6 Disease Treatment and Drug Discovery Process: Tablet Formulation Types and Requirements 6.2.7 Disease Treatment and Drug Discovery Process: Case study – Aprecia Pharmaceuticals6.3 Company Profile: Aprecia Pharmaceutical6.3.1 Company Profile: Aprecia Pharmaceutical – Technology/Product 6.4.1 Disease Treatment & Drug Discovery Process – Impact on Drug Screening and Toxicity Testing 6.4.2 Disease Treatment & Drug Discovery Process – Innovation Landscape 6.4.2 Disease Treatment & Drug Discovery Process – Innovation Landscape (continued)6.4.2 Disease Treatment & Drug Discovery Process – Innovation Landscape (continued) 6.4.3 Disease Treatment & Drug Discovery Process – Case study : Organovo6.4.4 Disease Treatment & Drug Discovery Process – Innovations in Emerging Markets – India & China 6.5.1 Operational Models of Pharma Business – 3DP a Major Point of Interest for Contract Manufacturers with Pharma Clients6.5.2 Operational Models of Pharma Business – Impact across Pharmaceutical R&D 6.5.3 Operational Models of Pharma Business – Benefits of 3D Printing Across Pharma Applications 6.5.4 Operational Models of Pharma Business – Current 3DP Implementation Strategies6.5.5 Operational Models of Pharma Business – Current 3DP Implementation Strategies by Big Pharma6.6 Drug Supply Chain: How is 3D Printing Interrupting the Drug Supply Chain? 6.7 Impact across Emerging Markets 6.8 Regulatory Landscape 6.9 Drivers and Restraints – Factors Aiding/Hindering Adoption of 3D Printing in the Pharma Industry6.10 Drivers Explained6.11 Restraints Explained6.12 Digital Fabrication’s Potential Impact on Drug Accessibility in Emerging Countries6.13 Strategic Recommendations on Steps Forward 7.0 Growth Opportunities and Companies to Action7.1 Growth Opportunity: 3D Printing for Healthcare7.2 Major Growth Opportunities for 3DP in Healthcare 7.3 Strategic Imperatives for 3DP Technology Stakeholders7.4 Epileptic Solutions Using 3D Printed Drugs – Aprecia Pharmaceutical, US8.0 Patent Landscape Overview & Key Contacts 8.1 Patent Search Scope8.2 Patent Publishing Trends, Global, 2011–20158.3 Top 20 Patent holders, Global, 2010–20158.4 Patents per Source Jurisdiction (Top 10 Patent offices), Global, 2010–20158.5 Key Company ContactsLegal Disclaimer9.0 The Frost & Sullivan Story9.1 The Frost & Sullivan Story9.2 Value Proposition: Future of Your Company & Career9.3 Global Perspective9.4 Industry Convergence9.5 360º Research Perspective9.6 Implementation Excellence9.7 Our Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.